CT-Soligenix, BDPENTO1, (P. Lee, PI) - A phase I/II study to evaluate escalating doses of SGX201 (delayed release oral beclomethasone dipropionate BDP) for prevention of signs and symptoms of acute enteritis in patients with rectal cancer treated with combined chemotherapy and radiation, PI, 5% effort, 3/15/11-3/14/14, $72,612.
NIH/National Cancer Institute, 7R01CA116712, D. Low, PI, Positron emission tomography for radiation therapy, Co-PI, 5% effort, 8/1/11-5/31/12, $1,519,743.
US Army/MRAA W81XWH1110531, W. McBride, PI, Radiation-induced vaccination to breast cancer, Co-Investigator, 5% effort, 9/30/11-10/29/15, $2,258,542.
NIH/National Cancer Institute, R21, K. Sheng, A mechanistic model to derive lung tumor motion from whole surface tracking, Co-Investigator, 5% effort, 2 years, $275,000.
NIH/National Cancer Institute, R21, D. Ruan. Sequential motion adaptive lung cancer RT, Co-Investigator, 5% effort, 2 years, $275,000.
Cacalano - CMCR Seed Grant U19: "Identification of radiation mitigators that act through the STAT3 pathway"
Schaue - 2U19 AI067769, NIAID Seed Grant (role: PI), 11/01/12-10/31/13, $50,000, "Autofluorescence is a tool to monitor radiation exposure and mitigation."
McBride - NIAID supplement
D Ruan - NIH sub in R01
Grants Awarded - Other Sponsored
E. Vlashi - UCLA CTSI Core Voucher (UL1TR000124) $10,000